Anti-Mouse CD178 (FasL) – Purified in vivo GOLD™ Functional Grade

Anti-Mouse CD178 (FasL) – Purified in vivo GOLD™ Functional Grade

Product No.: M351

- -
- -
Clone
MFL3
Target
CD178
Formats AvailableView All
Product Type
Monoclonal Antibody
Alternate Names
FasL, Fas Ligand, FasL, Apo-1 Ligand, CD95 Ligand, TNFSF6
Isotype
IgG
Applications
B
,
FC
,
IF
,
in vivo

- -
- -
Select Product Size
- -
- -

Antibody Details

Product Details

Reactive Species
Mouse
Host Species
Armenian Hamster
Recommended Dilution Buffer
Immunogen
B6 mouse FasL cDNA-transfected baby hamster kidney (B6 FasL/BHK) cells
Product Concentration
≥ 5.0 mg/ml
Endotoxin Level
< 1.0 EU/mg as determined by the LAL method
Purity
≥95% monomer by analytical SEC
>95% by SDS Page
Formulation
This monoclonal antibody is aseptically packaged and formulated in 0.01 M phosphate buffered saline (150 mM NaCl) PBS pH 7.2 - 7.4 with no carrier protein, potassium, calcium or preservatives added. Due to inherent biochemical properties of antibodies, certain products may be prone to precipitation over time. Precipitation may be removed by aseptic centrifugation and/or filtration.
Product Preparation
Functional grade preclinical antibodies are manufactured in an animal free facility using in vitro cell culture techniques and are purified by a multi-step process including the use of protein A or G to assure extremely low levels of endotoxins, leachable protein A or aggregates.
Storage and Handling
Functional grade preclinical antibodies may be stored sterile as received at 2-8°C for up to one month. For longer term storage, aseptically aliquot in working volumes without diluting and store at ≤ -70°C. Avoid Repeated Freeze Thaw Cycles.
Country of Origin
USA
Shipping
Next Day 2-8°C
Applications and Recommended Usage?
Quality Tested by Leinco
FC The suggested concentration for this CD178 antibody, clone MFL3, for staining cells in flow cytometry is ≤ 0.25 μg per 106 cells in a volume of 100 μl. Titration of the reagent is recommended for optimal performance for each application.
Additional Applications Reported In Literature ?
B
IF
Each investigator should determine their own optimal working dilution for specific applications. See directions on lot specific datasheets, as information may periodically change.

Description

Description

Specificity
Clone MFL3 recognizes an epitope on mouse FasL.
Background
FasL antibody, clone AFS98, recognizes Fas ligand (FasL), also known as CD178, Apo-1 ligand, and CD95 ligand. FasL is a 40 kDa type II integral membrane protein that belongs to the tumor necrosis factor (TNF) superfamily. FasL is expressed by activated T cells and natural killer (NK cells)1-3. Binding of FasL to its receptor Fas (CD95, APO-1) induces apoptotic cell death in Fas-expressing target cells, contributing to anti-viral immunity. FasL also contributes to peripheral tolerance and the downregulation of immune responses through activation-induced autocrine and paracrine T cell death4. FasL is also found in the anterior chamber of the eye and on Sertoli cells in the testis, and is implicated in immune-privilege at these sites5,6. FasL also contributes to CD8 proliferation and neutrophil recruitment7,8. Soluble FasL (26 kDa) can be released following cleavage by metalloproteinases and block FasL-mediated signaling9. Fas/FasL-signaling is involved in the development of many human diseases, including autoimmunity and cancer10. Many human tumors over-express FasL, resulting in tumor infiltrating lymphocyte (TIL) apoptosis and immune evasion, which is associated with poor prognosis11-14.
Antigen Distribution
FasL is expressed on activated T cells, NK cells, the eye, and testis.
Ligand/Receptor
Fas (CD95)
PubMed
NCBI Gene Bank ID
Research Area
Apoptosis
.
Cell Biology
.
Cell Death
.
Immunology
.
Neuroscience
.
Tumor Suppressors

Leinco Antibody Advisor

Powered by AI: AI is experimental and still learning how to provide the best assistance. It may occasionally generate incorrect or incomplete responses. Please do not rely solely on its recommendations when making purchasing decisions or designing experiments.

Applications of Clone MFL3 in In Vivo Mouse Studies

Clone MFL3 is a hamster-derived monoclonal antibody that specifically targets mouse Fas Ligand (FasL, CD178, CD95 Ligand, TNFSF6), a type II transmembrane glycoprotein in the TNF superfamily. It is widely used in immunological research to study the biological roles of FasL in mice, including immune regulation, apoptosis, and immune evasion by tumors.

Key Uses of MFL3 in Mouse Models

  • Blocking Apoptotic Signaling:
    MFL3 has been reported to efficiently block the cytotoxicity mediated by mouse Fas Ligand, thereby inhibiting CD178/CD95-induced apoptosis in vivo. This is particularly useful for investigating the role of the Fas/FasL pathway in immune homeostasis, autoimmunity, and inflammation.
  • Modulating Immune Responses:
    The Fas/FasL interaction is essential for peripheral tolerance and the regulation of immune responses, including T-cell development and the control of activated lymphocytes. MFL3 can be used to manipulate these pathways, such as by preventing the elimination of autoreactive lymphocytes or by altering T-cell-mediated cytotoxicity.
  • Tumor Immunology:
    Some tumors upregulate FasL to induce apoptosis of infiltrating immune cells, thus evading immune surveillance. MFL3 can be used to block this tumor-protective mechanism, potentially enhancing anti-tumor immune responses in mouse models of cancer.
  • Inflammation and Leukocyte Trafficking:
    Beyond apoptosis, FasL is also involved in neutrophil extravasation and chemotaxis. MFL3 can be used to study the inflammatory roles of FasL in vivo, for example, in models of inflammation or tissue injury.
  • Functional Grade for In Vivo Use:
    MFL3 is available in functional grade (low endotoxin, high purity), specifically formulated for in vivo administration in mice, allowing for direct manipulation of the Fas/FasL pathway in live animals.

Technical Considerations

  • Specificity: MFL3 recognizes an epitope on mouse FasL and does not cross-react with rat leukocytes, making it a reliable tool for mouse studies.
  • Activation Dependence: FasL is expressed at low levels on resting cells but is upregulated on activated T cells. To detect FasL expression ex vivo, cells must be appropriately activated, for example, with anti-CD3 antibodies.
  • Formulation: The antibody is typically administered intraperitoneally or intravenously, with dosing optimized for the experimental model and desired biological effect. Since applications vary, each investigator should titrate the reagent to achieve optimal results.
  • Control of Autoimmunity: Mice with defective FasL (gld mutants) develop autoimmune lymphoproliferative disease; MFL3 can be used to phenocopy or rescue aspects of this phenotype by modulating FasL activity.

Summary Table: In Vivo Uses of Clone MFL3

ApplicationPurposeMechanismReference
Apoptosis blockingStudy immune regulation, autoimmunityInhibits Fas/CD95-induced apoptosis
Tumor immunologyEnhance anti-tumor immunityBlocks tumor FasL-mediated evasion
InflammationModulate neutrophil recruitment, chemotaxisInhibits FasL proinflammatory role
Functional studiesManipulate immune homeostasis in vivoDirect in vivo administration

Conclusion

Clone MFL3 is a versatile tool for in vivo mouse studies, enabling researchers to block FasL-mediated apoptosis, modulate immune responses, investigate tumor immune evasion, and study inflammation. Its specific reactivity, functional blocking capability, and availability in in vivo-grade formulations make it a valuable reagent for dissecting the complex roles of the Fas/FasL pathway in mouse models.

I cannot find specific storage temperature information for the sterile packaged clone MFL3 in the provided search results. The search results contain storage temperature guidelines for various laboratory materials including Gibson Assembly kits, lambda vectors, ELISA kits, and general sterile supplies, but none specifically mention MFL3.

General Guidelines for Sterile Packaged Materials

While I cannot provide the exact storage temperature for MFL3, the search results do offer some general principles for storing sterile packaged items:

Standard Storage Conditions: The storage area for packaged sterilized items should be well ventilated and protected against dust, moisture, insects, and temperature and humidity extremes.

Common Laboratory Storage Temperatures: Many sterile biological materials are typically stored at standard laboratory temperatures such as:

  • -80°C for long-term storage of sensitive biological materials
  • -20°C for intermediate-term storage
  • 4°C for short-term storage (up to one month for some kits)

Recommendation

To determine the correct storage temperature for your specific sterile packaged clone MFL3, I recommend:

  1. Check the product documentation or packaging insert that came with MFL3
  2. Contact the manufacturer directly for official storage guidelines
  3. Consult your institution's protocols for similar sterile cloned materials

Without access to the specific product information for MFL3, I cannot provide the definitive storage temperature, as different cloned materials may have varying storage requirements depending on their composition and intended use.

Commonly Used Antibodies and Proteins with MFL3 in the Literature

MFL3 is a well-known Armenian hamster monoclonal antibody targeting mouse Fas ligand (CD178). It is widely used in immunological research, particularly in studies investigating apoptosis, T cell activation, and immune regulation.

Directly Co-Used Antibodies and Proteins

  • Anti-CD3 Antibodies: In immunological research, especially studies focused on T cell activation and apoptosis, MFL3 (anti-FasL) is often used alongside anti-CD3 antibodies to activate T cells and then assess FasL expression or function on activated T cells. While the search results do not specify a particular study pairing MFL3 with anti-CD3, this combination is frequently reported in the broader immunological literature, as anti-CD3 is a standard stimulus for T cell activation, and FasL (CD178) is upregulated upon T cell activation.
  • Anti-Fas (CD95) Antibodies: Fas ligand (FasL, CD178) exerts its apoptotic effect by binding to the Fas receptor (CD95). Therefore, antibodies against Fas (CD95) are sometimes used in parallel with MFL3 to study the Fas–FasL apoptotic pathway.
  • Conjugation Partners and Controls: MFL3 is available in a phycoerythrin (PE)-conjugated form, and in flow cytometry, it is routinely paired with other fluorescently labeled antibodies (e.g., anti-CD4, anti-CD8, anti-CD25) to enable multiparametric analysis of immune cell populations. However, the literature does not specify a standard or exclusive "partner" antibody; the combination depends on the experimental design.

Other Contextual Uses in the Literature

While the provided search results do not detail specific co-administration of MFL3 with Fc fusion proteins or albumin fusions, these protein classes are commonly used in antibody and protein therapeutic research, including studies on half-life extension and targeted delivery. However, there is no direct evidence that MFL3 is routinely used with these molecules in the cited literature.

Summary Table

Antibody/ProteinRole/Function in Combination with MFL3Rationale/Context
Anti-CD3T cell activation (stimulus for FasL expression)Allows study of FasL on activated T cells
Anti-CD95 (Fas)Apoptosis receptor detectionPartners with FasL in apoptotic signaling pathway
Fluorescent antibodies (e.g., CD4, CD8, CD25)Multiparametric flow cytometryRoutine for phenotyping immune cell subsets

Conclusions

MFL3 is most commonly used in the literature alongside anti-CD3 antibodies and anti-Fas (CD95) antibodies for investigating T cell activation and apoptosis pathways, respectively. In flow cytometry, it is paired with a range of fluorescently labeled antibodies for detailed immune cell analysis. No standard co-use with Fc fusion proteins or albumin fusions is indicated in the provided literature.

Clone MFL3 is a monoclonal antibody widely cited in scientific literature for its role in detecting and functionally blocking mouse Fas Ligand (FasL, CD178), a key mediator in apoptotic cell death and immune regulation.

Key findings from citations of clone MFL3 in scientific literature include:

  • Specificity to Mouse FasL (CD178): MFL3 reacts with mouse FasL, a member of the TNF superfamily expressed on activated T cells, NK cells, and immune-privileged sites like the eye and testis.
  • Functional Blocking of Apoptosis: MFL3 has been reported to block FasL-induced apoptosis, demonstrating utility in functional studies of T cell regulation and cell-mediated cytotoxicity.
  • Immunological Applications: The antibody is primarily used for flow cytometry (FCM), allowing quantification and characterization of FasL-expressing cells in murine models. Recommended concentration for flow cytometry is ? 0.25 ?g per 10^6 cells in 100 ?L volume.
  • Contribution to Peripheral Tolerance and Anti-Viral Immunity: Research using MFL3 shows FasL’s critical role in inducing apoptosis of activated T cells, contributing to the maintenance of immune tolerance and regulation of immune responses.
  • Citations and Usage: Product databases and catalogs indicate clone MFL3 is cited in at least 5 scientific publications for its role in murine immunology and apoptosis research.

Summary of supporting details:

  • Background: FasL (CD178) is a 40 kDa transmembrane protein involved in triggering apoptosis through interaction with its receptor Fas (CD95).
  • Mechanistic Insight: Studies using MFL3 have helped elucidate the role of FasL in immune privileged sites and in T cell developmental processes.
  • Experimental Utility: Clone MFL3's blocking activity is utilized to experimentally dissect FasL-mediated apoptotic pathways and their implications in immune response and disease models.

In sum, clone MFL3 citations underscore its importance as an investigative tool in murine FasL biology, immune regulation, and functional blocking of apoptosis in preclinical studies.

References & Citations

1. Okumura K., et al. (1994) Proc Natl Acad Sci USA. 91:4930–4934
2. Nagata S., et al. (1995) J Immunol. 154:3806–3813
3. Saito T., et al. (1995) J Exp Med. 181:1235–1238
4. Ferguson T A., et al. (1995) Science. 270:1189–1192
5. Duke R C., et al. (1995) Nature (London). 377:630–632
6. Fink PJ. (2000) J Immunol. 165(10):5537-43
7. Matsuzawa A., et al. (1998) J Immunol. 161: 4484–4488
8. Nagata S., et al. (1998) Nat Med. 4(1):31-6
9. Hueber AO., et al (2019) Cancers (Basel). 11(5):639
10. Kabelitz D., et al. (2000) Cancer Res. 60: 822–828
11. Giannarelli D., et al. (2000) Int J Cancer. 89: 127–132
12. Kanno H., et al. (2000) Br J Cancer. 82: 1446–1452.
13. Nagano H., et al. (Cancer) Br J Cancer. 82: 1211–1217
B
Flow Cytometry
IF
in vivo Protocol

Certificate of Analysis

Formats Available

- -
- -
Disclaimer AlertProducts are for research use only. Not for use in diagnostic or therapeutic procedures.